| Title | Date | PubMed ID |
|---|
| Homozygous null mutations in ZMPSTE24 in restrictive dermopathy: evidence of genetic heterogeneity. | 2012 Feb | 21108632 |
| Requirements for efficient proteolytic cleavage of prelamin A by ZMPSTE24. | 2012 | 22355414 |
| HIV protease inhibitors inhibit FACE1/ZMPSTE24: a mechanism for acquired lipodystrophy in patients on highly active antiretroviral therapy? | 2010 Feb | 20074077 |
| Novel frameshifting mutations of the ZMPSTE24 gene in two siblings affected with restrictive dermopathy and review of the mutations described in the literature. | 2010 Feb | 20101687 |
| Accelerated features of age-related bone loss in zmpste24 metalloproteinase-deficient mice. | 2009 Oct | 19587107 |
| HIV protease inhibitors block the zinc metalloproteinase ZMPSTE24 and lead to an accumulation of prelamin A in cells. | 2007 Aug 14 | 17652517 |
| Inhibition of the CaaX proteases Rce1p and Ste24p by peptidyl (acyloxy)methyl ketones. | 2007 Jun | 17467817 |
| Homozygous and compound heterozygous mutations in ZMPSTE24 cause the laminopathy restrictive dermopathy. | 2005 Nov | 16297189 |
| Accelerated ageing in mice deficient in Zmpste24 protease is linked to p53 signalling activation. | 2005 Sep 22 | 16079796 |
| Prelamin A endoproteolytic processing in vitro by recombinant Zmpste24. | 2005 Apr 1 | 15479156 |